NY-SOLIDUS-LABS
Solidus Labs , the category-definer for crypto-native market integrity solutions, announced today the launch of HALO , the first automated, comprehensive and testable trade surveillance and market integrity hub tailored for digital assets.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220323005138/en/
HALO’s launch will be instrumental in shaping the future of financial risk monitoring. Built from the ground up to bridge the gap between crypto and traditional finance, HALO provides Wall-Street grade crypto-native regulatory risk and compliance solutions. Increasingly, financial institutions are relying on HALO as they expand into new revenue opportunities offered by digital assets. Beyond a growing client-base of crypto and DeFi businesses, HALO is also set to offer government agencies tools to create transparency, enable innovative regulatory frameworks and ensure safe and regulated crypto financial services in their jurisdictions. The platform addresses numerous crypto-specific challenges, like new market structures, volatility, volumes, data types, decentralized services, trading dynamics, crypto-native market abuse typologies - and evolving business and regulatory demands.
“Crypto’s potential to make financial services more accessible, transparent, liquid and efficient, depends on state-of-the-art financial risk monitoring that enables the merits of digital assets, while surgically mitigating its many new risks,” said Asaf Meir, Founder and CEO of Solidus Labs. “HALO does that by unifying formerly disparate risk data points, and continually monitoring that data in real-time, creating a behavioral-based universal client risk profile that allows our clients to focus on real risk, in real-time, throughout the investment journey.”
Combining cutting edge machine learning technology and decades of traditional financial risk know-how and best practices, HALO is uniquely tailored to address the “triple T” (T3) pillars of market integrity in the crypto and DeFi space - trade surveillance, transaction monitoring, and threat intelligence. HALO’s modules include:
Trade Surveillance: HALO’s comprehensive market surveillance tools ensure market integrity by benchmarking abnormal crypto orders and execution patterns against the market norm, to alert businesses and networks on potential breaches of trading rules or unusual market volatility. HALO users can easily customize detection model sensitivity and backtest against real data in order to meet the needs of quickly evolving regulatory and compliance landscapes.
Transaction monitoring: HALO’s continuous real-time monitoring of crypto and fiat transactions offers unprecedented blockchain-native capabilities and enables detecting, investigating and reporting suspicious crypto deposits and withdrawals for anti-money laundering (AML), sanctions, and financial risk compliance.
Threat Intelligence: Relying on a built-in onboarding verification tool, powerful integrations and crypto-native infrastructure, HALO’s Universal Client Risk Profile aggregates risk across the entire investment journey and multiple markets - from onboarding to trading, post-trade and everything in between. Synthesizing numerous signals into a single threat intelligence hub, HALO surgically surfaces overlooked threats in crypto and DeFi services, enabling businesses to act upon them in real time.
HALO currently protects more than 25 million retail and institutional investors globally, and is actively used to monitor over one trillion events per day. The platform deploys over 50 different proprietary market abuse typologies, shielding investors and safeguarding crypto businesses from new threats unique to the crypto and decentralized finance space. “Since our founding, our deepest commitment has been to enable a safer crypto ecosystem. HALO brings us one step closer to that goal while taking user experience to the next level, empowering risk and compliance teams and allowing crypto businesses to grow safer,” Meir said. “It’s a culmination of thousands of hours of work with crypto teams and discussions with regulators, fulfilling our vision of harnessing crypto not only as an opportunity to transform financial services, but also as an opportunity to take financial risk monitoring into the future.”
To learn more about Solidus Labs and HALO visit: www.soliduslabs.com
About Solidus Labs:
Solidus Labs is the category-definer for crypto-native triple T (T3) market integrity solutions - trade surveillance, transaction monitoring, and threat intelligence.
Our mission is to enable safer crypto trading throughout the investment journey across all centralized and DeFi markets. As the founder of industry leading initiatives like the Crypto Market Integrity Coalition and DACOM Summit , and in everything we do, Solidus is deeply committed to ushering in the financial markets of tomorrow.
Crypto exchanges, financial institutions and regulators globally rely on Solidus HALO - our real time, comprehensive, testable, and future-proof platform. Safeguarding their business from known forms of market abuse and a plethora of emerging crypto-specific risks, we enable our clients to grow faster - and safer.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220323005138/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Enginzyme and AGC Create Scalable Process for Key mRNA Ingredient12.1.2026 06:00:00 CET | Press release
At the mRNA Health conference in Berlin, enginzyme and AGC Inc. presented a scalable process to produce a key mRNA vaccine and therapy ingredient, N1-methylpseudouridine-5'-triphosphate (m¹ΨTP). The rapid growth of mRNA-based vaccines and therapeutics has driven significant demand for modified nucleotides like m¹ΨTP, which enhances mRNA stability and expression, while reducing immunogenicity. Enginzyme is a deep-tech company delivering optimized biomanufacturing solutions through cell-free enzyme engineering technology. AGC Inc. is a leading global player in fields spanning from architectural glass to chemicals and life science. AGC Inc. provides services in a wide range of life science fields, from synthetic pharmaceuticals and agrochemicals, to biopharmaceuticals and leading-edge cell and gene therapies, as well as messenger RNAs. The presentation in November detailed the latest collaboration between the companies, with a focus on the biomanufacturing of nucleotides for mRNA therapy,
Ant International Partners with Google’s Universal Commerce Protocol to Expand AI Capabilities12.1.2026 02:15:00 CET | Press release
Ant International, a leading global payment, digitisation, and financial technology provider, is collaborating on the launch of Google’s Universal Commerce Protocol (UCP), a new open standard for agentic commerce that works across the entire shopping journey — from discovery and buying to post-purchase support. UCP establishes a common language for agents and systems to operate together across consumer surfaces, businesses, and payment providers to enable commerce. So instead of requiring unique connections for every individual agent, UCP enables all agents to interact easily. UCP is built to work across verticals and is compatible with existing industry protocols like Agent2Agent (A2A), Agent Payments Protocol (AP2), and Model Context Protocol (MCP). “For agentic commerce to scale, it’s critical for the industry to align on a common set of standards. We are proud to have Ant International endorse the Universal Commerce Protocol as the foundation for that future,” said Ashish Gupta, VP
Torq Secures $140M Series D at $1.2B Valuation to Lead the AI SOC and Agentic AI Era11.1.2026 17:59:00 CET | Press release
Fueled by Massive Customer Adoption of AI Agents, Torq Scales the World’s First True AI SOC Platform and Accelerates Expansion into the U.S. Federal Market Torq, the established Agentic AI security operations pioneer, today announced it has closed a massive $140 million Series D funding round, propelling its valuation to $1.2 billion and total funding to $332M. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260112510774/en/ Led by Merlin Ventures—a leading cybersecurity fund renowned for its deep access to the U.S. commercial and Public Sector markets—with participation from all existing investors, including Evolution Equity Partners, Notable Capital, Bessemer Venture Partners, Insight Ventures Partners, and Greenfield Partners, this capital injection is a definitive investment in the future of security. Torq is driving the industry’s critical shift: the complete transformation of the Security Operations Center (SOC) through
Andersen udvider sine kompetencer med tilføjelsen af Scimitar9.1.2026 21:44:00 CET | Pressemeddelelse
Andersen Consulting har indgået en samarbejdsaftale med Scimitar, der er et firma med fokus på at accelerere innovation i biovidenskabsbranchen. Scimitar, der har hovedkvarter i USA, et førende konsulenthus inden for strategieksekvering for biovidenskabsbranchen. Virksomheden er specialiseret i design af driftsmodeller, digital transformation og organisatorisk forandring. Scimitar samarbejder med medicinal- og biotech-virksomheder om at accelerere innovation, styrke den driftsmæssige eksekvering og sikre compliance gennem hele produkters livscyklus. Deres praktiske og samarbejdsorienterede tilgang sikrer løsninger, der ikke blot er formålstjenlige, men også skalerbare. "Virksomheder inden for biovidenskabsbranchen befinder sig i en tid med hurtige videnskabelige fremskridt, stigende regulatorisk kompleksitet og et voksende behov for operationel agilitet, samtidig med at de holdes op mod de højeste standarder for patientsikkerhed og dataintegritet," udtaler Ramy Khalil, CEO i Scimitar.
Biocytogen and Acepodia Expand Collaboration Through Option-based Evaluation Framework for First-in-Class Bispecific and Dual-Payload ADCs (BsAD2C)9.1.2026 13:00:00 CET | Press release
Expanded collaboration builds on Acepodia and Biocytogen’s recent co-development efforts to evaluate selected bispecific antibody and dual-payload ADC programs Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315) and Acepodia (6976:TT), today announced that the companies have entered into an option and license agreement designed to enable the structured evaluation of bispecific antibody-drug conjugate (BsADC) programs to further advance the development of dual-payload bispecific antibody-drug conjugates (BsAD2Cs). The agreement grants Acepodia an option to obtain an exclusive worldwide license from Biocytogen for two BsADC programs. Under the terms of the agreement, Biocytogen is eligible to receive an upfront option fee and, upon Acepodia’s exercise of the option, additional payments including option exercise fees, development, regulatory, and commercial milestone payments, as well as royalties on future product sales. The financial terms of the agreem
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom